Results 61 to 70 of about 29,938 (169)

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil

Brazilian Journal of Infectious Diseases, 2014
Objectives: To analyze the behavior of meningococcal disease in the Federal District, Brazil, from 2005 to 2011, and to assess the direct impact of the meningococcal serogroup C conjugate vaccine.
Márcia de Cantuária Tauil, Cleidiane Santos Rodrigues de Carvalho, Ataiza César Vieira, Eliseu Alves Waldman   +3 more
doaj   +1 more source

Exploring the sequence diversity and surface expression of Factor H-Binding Protein among invasive serogroup B meningococcal strains from selected European countries

Human Vaccines & Immunotherapeutics
Factor H-Binding Protein (fHbp) is a key component of meningococcal vaccines such as MenB-fHbp, licensed in the EU, UK, and other countries. Sufficient expression of fHbp on the bacterial surface is necessary for vaccine-induced antibodies to bind and ...
Stephen A. Clark, Laura Willerton, Heike Claus, Anna Carannante, Paola Stefanelli, Raquel Abad, Julio A. Vázquez, Ray Borrow   +7 more
doaj   +1 more source

Fatal Nongroupable Neisseria meningitidis Disease in Vaccinated Patient Receiving Eculizumab

Emerging Infectious Diseases, 2018
Patients receiving eculizumab have an increased risk for meningococcal disease, but most reported cases are attributable to encapsulated meningococcal strains.
Deirdre Nolfi-Donegan, Monica Konar, Vianca Vianzon, Jessica MacNeil, James Cooper, Perrianne Lurie, Judi Sedivy, Xin Wang, Dan M. Granoff, Lucy McNamara   +9 more
doaj   +1 more source

A Comprehensive Review of Meningococcal Disease Burden in India

Infectious Diseases and Therapy, 2020
Introduction Meningococcal disease caused by Neisseria meningitidis has a high case fatality rate. Of 12 distinct serogroups, A, B, C, W-135 (W) and Y cause the majority of infections.
Ashok Kumar Dutta, Subramanian Swaminathan, Veronique Abitbol, Shafi Kolhapure, Sripriya Sathyanarayanan   +4 more
doaj   +1 more source

Meningococcal typing [PDF]

Journal of Medical Microbiology, 1994
M C, Maiden, I M, Feavers
openaire   +2 more sources

Rapid Recognition of Carfilzomib‐Induced Thrombotic Microangiopathy and Early Application of Eculizumab Successfully Rescued Two Relapsed Myeloma Patients

Chronic Diseases and Translational Medicine, Volume 12, Issue 1, Page 63-68, March 2026.
Zi Wang, Hua Zheng, Wei Wang, Xiaoxiao Shi, Yunpeng Wei, Chao Li, Junling Zhuang   +6 more
wiley   +1 more source

Meningococcal pneumonia: a review

Pneumonia, 2019
Background Although Neisseria meningitidis is one of the major causes of meningitis, meningococcal pneumonia is the most common non-neurological organ disease caused by this pathogen.
Charles Feldman, Ronald Anderson
doaj   +1 more source

Meningococcal Meningitis [PDF]

Medical Journal Armed Forces India, 2005
Sharat, Johri, S P, Gorthi, A C, Anand
openaire   +2 more sources

Meningococcal Vaccines

Pediatric Infectious Disease Journal, 2004
The 5 major pathogenic serogroups of the Gram-negative encapsulated bacterium Neisseria meningitidis are A, B, C, Y, and W135. In the 1960s, vaccines consisting of purified capsular polysaccharide antigens were developed against serogroups A, C, Y, and W135.
openaire   +3 more sources

The important lessons lurking in the history of meningococcal epidemiology

Expert Review of Vaccines
Introduction The epidemiology of invasive meningococcal disease (IMD), a rare but potentially fatal illness, is typically described as unpredictable and subject to sporadic outbreaks.Areas covered Meningococcal epidemiology and vaccine use during the ...
Ray Borrow, Jamie Findlow
doaj   +1 more source